Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs

Conditions: Hemophilia A Interventions: Genetic: Single dose intravenous injection of BBM-H803 Sponsors: Shanghai Belief-Delivery BioMed Co., Ltd; Shanghai MYGT Biopharmaceutical LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials